STRATA Skin Sciences Shares Fall 21% Amid Johns Hopkins Dermatology Program Expansion

miércoles, 18 de febrero de 2026, 11:08 am ET1 min de lectura
SSKN--

STRATA Skin Sciences shares fell 21% despite the company announcing that Johns Hopkins Dermatology added the XTRAC 308 nm excimer laser to its clinical offerings. The addition strengthens Johns Hopkins' capabilities in treating chronic inflammatory and autoimmune skin conditions. STRATA CEO Dr. Dolev Rafaeli highlighted the critical role of academic medical centers in advancing precision treatment strategies.

STRATA Skin Sciences Shares Fall 21% Amid Johns Hopkins Dermatology Program Expansion

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios